维普中文期刊产品整合服务
15篇 您的检索式:作者名="Patyna"
    题名 作者 年代 出处 被引量
1Three-dimensional analysis of the physiological foramen geometry of maxillary and mandibular molars by means of micro-CT显示文摘The aim of this study was to investigate the physiological foramen diameter, shape and distance between physiological and anatomical apex of maxillary and mandibular first and second molars. Accurate knowledge of the physiological foramina morphology; thus, inherent mechanical shaping technical hindrances, is decisive when taking the corresponding root canal final preparation decision. The morphological dimensions of a total of 1 727 physiological foramina were investigated by means of micro-computed tomography. Mean narrow and wide(to a high number, oval) diameters of the physiological foramen were 0.24,0.22 and 0.33 mm and 0.33, 0.31 and 0.42 mm in mesiobuccal(MB), distobuccal(DB) and palatal(P) roots in maxillary first molars; 0.24, 0.22 and 0.33 mm and 0.41, 0.33 and 0.44 in MB, DB, and P roots in maxillary second molars. Mandibular first molars showed mean narrow and wide diameters of 0.24 and 0.30 mm and of 0.39 and 0.46 mm in mesial(M) and distal(D)roots; second mandibular molars showed 0.25 and 0.31 mm and 0.47 mm in M and D roots. The mean distance between the physiological foramina and anatomical apex was 0.82, 0.81 and 1.02 mm and 0.54, 0.43 and 0.63 mm in MB, DB and P roots of the maxillary first and second molars, respectively. A mean distance of 0.95 mm(M) and 1.05 mm(D) in the first and0.78 mm(M) and 0.81 mm(D) in the second mandibular molars was observed. Based on the results obtained, assumable recommendations for final preparation size of the physiological foramen were calculated. However, when taking into consideration, the resulting standard deviations of marginal errors must be cautiously considered when taking a final decision in clinical endodontic treatment.Thomas Gerhard Wolf Frank Paqué Michael Sven Patyna Brita Willershausen Benjamín Briseno-Marroquín 2017International Journal of Oral Science2017,9,3:4
2SU14813 : a novel multiple receptor tyrosine kinase inhibitor with potent antiangiogenic and antitumor activity 显示文摘PATYNA S LAIRD A D MENDEL D B 2006Mol Cancer Ther2006,5,7:1
3A proposed multigeneration protocol for Japanese medaka(Oryzias latipes ) to evaluate effects of en- docrine disruptQrs显示文摘Patyna P J Davi R A Parkerton T F 1999The Science of the Total Environment1999,233,13:1
4Evaluation of the safety and pharmacokinetics of the multi-targeted receptor tyrosine kinase inhibitor sunitinib during embryo-fetaldevelopment in rats and rabbits 显示文摘Patyna S Haznedar J Morris D 2009Birth Defects Res B Dev Reprod Toxicol2009,86,4:1
5Hazard evaluation of anddiisodecyl phthalate and diisodecyl phthalate in a Japanesemedaka mnhigenerational assay 显示文摘Patyna P J Brown R P Davi R A 2006Ecotoxicol Environ Saf2006,65,1:1
6A proposed multigeneration protocol for Japanese medaka (Oryzias latipes) to evaluate effects of endocrine disruptors 显示文摘Patyna PJ Davi RA Parkerton TF 1999Sci Total Environ1999,233,13:1
7Phase II Study of Sunitinib in Patients with Non-small Cell Lung Cancer and Irradiated Brain Metastases显示文摘Silvia Novello Carlos Camps Francesco Grossi Julien Mazieres Lauren Abrey Jean-Marc Vernejoux Aron Thall Shem Patyna Tiziana Usari Zhixiao Wang Richard C. Chao Giorgio Scagliotti 2011Journal of Thoracic Oncology2011,,7:1
8A proposed muhigeneration protocol for Japanese medaka ( Oryzias latipes) to evalu- ate effects of endocrine disruptors显示文摘PATYNA P J DAVI R A PARKERTON T F 1999Science of the Total Environment1999,233,123:1
9Hazard evaluation of diisononyl phthalate and diisodecyl phthalate in a Japanese medaka multigenerational assay 显示文摘Patyna PJ Brown RP Davi RA 2006Ecology and Environmental Safety2006,65,:1
10SU14813: a novel multiple receptor tyrosine kinase inhibitor with potent antiangiogenic and antitumor activity显示文摘PATYNA S LAIRD AD MENDEL DB 2006Mol Cancer Ther2006,5,7:1
11SU14813:a novel multiple receptor tyrosine kinase inhibitor with potent antiangiogenic and antitumor activity 显示文摘PATYNA S LAIRD AD MENDEL DB 2006Mol Cancer Ther2006,5,7:1
12Single- and multiple- dose disposition kinetics of sunitinib malate, a multitargeted receptor tyrosine kinase inhibitor: comparative plasma kinetics in non-clinical species 显示文摘Haznedar JO Patyna S Bello CL 2009Cancer Chemother Pharmacol2009,64,4:1
13SU14813: a novel multiple receptor tyrosine kinase inhibitor with potent antiangiogenic and antitumor activity 显示文摘Patyna S Laird AD Mendel DB 2006Mol Cancer Ther2006,5,7:1
14SU14813: a novel multiple receptor tyrosine kinase inhibitor with potent antiangiogenic and antitumor activity 显示文摘Patyna S Laird AD Mendel DB 2006Mol Cancer Ther2006,5,7:1
15A proposed multigeneration protocol for Japanese medaka (Oryzias latipes) to evaluate effects of endocrine disrupters 显示文摘Patyna PJ Davi RA Parkerton TF 1999Sci Total Environ1999,233,3:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费